High court clears way for clinical trial giving puberty blockers to children
King's College London says particular care will be taken over the safety of participants, who will be aged between 11 and 16. Photograph: camberwell.camera/AlamyView image in fullscreenKing's College London says particular care will be taken over the safety of participants, who will be aged between 11 and 16. The medical profession and morality do not always walk hand in hand.
- ▪King's College London says particular care will be taken over the safety of participants, who will be aged between 11 and 16.
- ▪Photograph: camberwell.camera/AlamyView image in fullscreenKing's College London says particular care will be taken over the safety of participants, who will be aged between 11 and 16.
- ▪The medical profession and morality do not always walk hand in hand.
The Guardian — UK publishes from United Kingdom and files mainly under news. We currently carry 236 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | The Guardian — UK |
| Canonical URL | https://www.theguardian.com/society/2026/jul/31/high-court-clinical-trial-puberty-blockers-children |
| Publication time | Fri, 31 Jul 2026 17:52:30 GMT |
| Retrieval time | 2026-07-31T17:58:30.289Z |
| Last seen | 2026-07-31T17:58:30.289Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | CIK9Zdzq7xnI · 1 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
King's College London says particular care will be taken over the safety of participants, who will be aged between 11 and 16. Photograph: camberwell.camera/AlamyView image in fullscreenKing's College London says particular care will be taken over the safety of participants, who will be aged between 11 and 16. Photograph: camberwell.camera/AlamyTransgenderHigh court clears way for clinical trial giving puberty blockers to childrenLegal challenge to King’s College London research study claimed it could harm participants but was rejectedKevin RawlinsonFri 31 Jul 2026 13.52 EDTLast modified on Fri 31 Jul 2026 13.54 EDTSharePrefer the Guardian on GoogleA clinical trial of drugs that can delay puberty can go ahead after a high court judge threw out a legal challenge on Friday.Campaigners had…
Excerpt limited to ~120 words for fair-use compliance. The full article is at The Guardian — UK.